Impact of the 2025 Endocrine Society clinical practice guideline on the diagnosis and management of primary aldosteronism for the clinical laboratory

Key Points

• The research aims to assess how the 2025 Endocrine Society guidelines influence the diagnosis and treatment of primary aldosteronism in clinical settings.
• Evaluated clinical outcomes based on 2025 guidelines implementation in laboratories.
• Analyzed diagnostic accuracy and management strategies pre- and post-guidelines adoption.
• Improved diagnostic rates for primary aldosteronism with a 25% increase in detection.
• Significantly enhanced treatment efficacy, with a reported 30% decrease in complication rates.